Jon Lamvik

1.2k total citations
58 papers, 877 citations indexed

About

Jon Lamvik is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Jon Lamvik has authored 58 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 19 papers in Molecular Biology and 16 papers in Hematology. Recurrent topics in Jon Lamvik's work include Immunotherapy and Immune Responses (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Immune Response and Inflammation (6 papers). Jon Lamvik is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Immune Response and Inflammation (6 papers). Jon Lamvik collaborates with scholars based in Norway, United States and Netherlands. Jon Lamvik's co-authors include Terje Espevik, Anders Waage, Peter Johan Moe, R. J. W. Rees, Tore Godal, H. M. Høyeraal, Geirmund Unsgaard, Jens Hammerstrøm, Anders Waage and Nina‐Beate Liabakk and has published in prestigious journals such as Blood, The Journal of Urology and British Journal of Haematology.

In The Last Decade

Jon Lamvik

55 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Lamvik Norway 15 322 247 203 160 134 58 877
D.G. Chalmers United Kingdom 16 282 0.9× 214 0.9× 176 0.9× 93 0.6× 102 0.8× 36 911
T. A. McNeill United Kingdom 20 396 1.2× 182 0.7× 169 0.8× 164 1.0× 190 1.4× 56 1.1k
C. Vincent France 18 272 0.8× 285 1.2× 134 0.7× 121 0.8× 113 0.8× 63 1.1k
S Douches United States 9 437 1.4× 254 1.0× 244 1.2× 257 1.6× 77 0.6× 11 1.1k
Jeremiah J. Twomey United States 15 355 1.1× 90 0.4× 117 0.6× 116 0.7× 115 0.9× 28 750
R. van Furth Netherlands 17 505 1.6× 366 1.5× 79 0.4× 248 1.6× 152 1.1× 29 1.2k
Jacinto J. Vazquez United States 14 270 0.8× 303 1.2× 121 0.6× 61 0.4× 87 0.6× 25 1.1k
B A Fiedel United States 15 234 0.7× 277 1.1× 176 0.9× 66 0.4× 245 1.8× 37 948
W G Reeves United Kingdom 23 363 1.1× 404 1.6× 119 0.6× 62 0.4× 123 0.9× 59 1.4k
N Génetet France 18 509 1.6× 261 1.1× 140 0.7× 205 1.3× 65 0.5× 54 1.0k

Countries citing papers authored by Jon Lamvik

Since Specialization
Citations

This map shows the geographic impact of Jon Lamvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Lamvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Lamvik more than expected).

Fields of papers citing papers by Jon Lamvik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Lamvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Lamvik. The network helps show where Jon Lamvik may publish in the future.

Co-authorship network of co-authors of Jon Lamvik

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Lamvik. A scholar is included among the top collaborators of Jon Lamvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Lamvik. Jon Lamvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammerstrøm, Jens, et al.. (2004). Høydosebehandling med stamcellestøtte i Midt-Norge. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
2.
Lamvik, Jon, et al.. (2001). Nonlabeled secondary antibodies augment/maintain the binding of primary, specific antibodies to cell membrane antigens. Cytometry. 45(3). 187–193. 10 indexed citations
3.
Gulbrandsen, Nina, Finn Wislöff, Lorentz Brinch, et al.. (2001). Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support. Medical Oncology. 18(1). 65–78. 73 indexed citations
4.
Hjorth‐Hansen, Henrik, et al.. (1999). Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia. European Journal Of Haematology. 62(2). 129–134. 19 indexed citations
5.
Tangen, Jon‐Magnus, Finn Wislöff, Michael Abdelnoor, et al.. (1997). Survival in 86 patients, aged 15–60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990–1995. European Journal Of Haematology. 59(2). 110–114. 1 indexed citations
6.
Waage, Anders, Daniel G. Remick, Sigurd Steinshamn, Laura DeForge, & Jon Lamvik. (1994). Interleukin 8 in serum in granulocytopenic patients with infections. British Journal of Haematology. 86(1). 36–40. 24 indexed citations
7.
Lamvik, Jon, Ingunn Dybedal, Jens Hammerstrøm, & Anders Waage. (1994). Acute Leukemia in Middle Norway 1984-88. Leukemia & lymphoma. 16(1-2). 65–71. 6 indexed citations
8.
Keldsen, Nina, Ole Weis Bjerrum, Inger Marie S. Dahl, et al.. (1993). Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study. European Journal Of Haematology. 51(2). 80–85. 3 indexed citations
9.
Shalaby, M R, Jostein Halgunset, L Aarden, et al.. (1991). Cytokine-associated tissue injury and lethality in mice: A comparative study. Clinical Immunology and Immunopathology. 61(1). 69–82. 22 indexed citations
10.
Romslo, Inge, et al.. (1990). Anemia in general practice Which laboratory tests are requested - how are the results interpreted and what are the consequences to patient care. Scandinavian Journal of Clinical and Laboratory Investigation. 50(sup200). 46–54. 3 indexed citations
11.
Romslo, Inge, et al.. (1990). Anemia in general practice. Scandinavian Journal of Clinical and Laboratory Investigation. 50(sup200). 41–45. 6 indexed citations
12.
Hannisdal, Einar, Odd Kildahl‐Andersen, Kjell A. Grøttum, & Jon Lamvik. (1990). Prognostic factors in multiple myeloma in a population‐based trial. European Journal Of Haematology. 45(4). 198–202. 20 indexed citations
13.
14.
Kildahl‐Andersen, Odd, Gordon H. Burgess, Savina Jaeger, et al.. (1988). Multiple myeloma in central and northern Norway 1981–1982: A follow‐up study of a randomized clinical trial of 5‐drug combination therapy versus standard therapy. European Journal Of Haematology. 41(1). 47–51. 11 indexed citations
15.
Lamvik, Jon, et al.. (1987). [Protein C deficiency. A possible cause of fetal death and recurrent venous thrombosis].. PubMed. 107(8). 739–40. 3 indexed citations
16.
Unsgaard, Geirmund, et al.. (1983). Depression of Monocyte-Mediated Cytotoxicity by Renal Carcinoma and Restoration Through Therapy. The Journal of Urology. 130(3). 620–620. 1 indexed citations
17.
Lamvik, Jon. (1968). Antibody Synthesis by Blastoid Cells Transformed in vitro from Rabbit Blood Lymphocytes. Scandinavian Journal of Haematology. 5(3). 171–178. 8 indexed citations
18.
Lamvik, Jon. (1967). The Transformation of Human Mononuclear Leukocytes in vitro. Acta Haematologica. 37(1). 32–41. 3 indexed citations
19.
Lamvik, Jon. (1963). RHEUMATOID PNEUMOCONIOSIS. Acta Pathologica Microbiologica Scandinavica. 57(2). 169–174. 7 indexed citations
20.
Ofstad, Jarle, et al.. (1961). ADRENAL STEROID SYNTHESIS IN AMYLOID DEGENERATION LOCALISED EXCLUSIVELY TO THE ZONA RETICULARIS. European Journal of Endocrinology. 37(3). 321–328. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.G. Chalmers Breakdown of academic impact, for papers by T. A. McNeill Breakdown of academic impact, for papers by C. Vincent Breakdown of academic impact, for papers by S Douches Breakdown of academic impact, for papers by Jeremiah J. Twomey Breakdown of academic impact, for papers by R. van Furth Breakdown of academic impact, for papers by Jacinto J. Vazquez Breakdown of academic impact, for papers by B A Fiedel Breakdown of academic impact, for papers by W G Reeves Breakdown of academic impact, for papers by N Génetet
Rankless by CCL
2026